NCT00780312

Brief Summary

The purpose of this study is to investigate whether the extent of late sequelae symptoms(reduced mouth opening, lymphoedema, decreased range of motion in the neck and shoulder region, speech and swallow disorders and reduced facial expression) due to radiotherapy treatment for head and neck cancer can be reduced by an individually adjusted physiotherapy effort applied immediately after the onset of and during radiotherapy treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2008

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 27, 2008

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2008

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

July 2, 2013

Status Verified

July 1, 2012

Enrollment Period

3.2 years

First QC Date

October 24, 2008

Last Update Submit

July 1, 2013

Conditions

Keywords

radiotherapytrismusphysiotherapylymphoedemalate side effectsfibrosisdecreased cervical range of motionquality of life

Outcome Measures

Primary Outcomes (1)

  • The amplitude of mouth opening

    Maximum vertical dimension measured in millimetre using TheraBite "Range of Motion Scale"

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

Secondary Outcomes (6)

  • Tongue movement

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

  • Active range of motion of the cervical spine

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

  • Lymphoedema

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

  • Tightness of tissue

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

  • Self estimated quality of life rating. EORTC QLQ-C30 and QLQ-H&N35

    Baseline: day 1 or 2 of radiotherapy treatment, 5 months after completing radiotherapy treatment and 12 months after completing radiotherapy treatment

  • +1 more secondary outcomes

Study Arms (2)

2

NO INTERVENTION

50 patients in this group get the existing hospital treatment: A 10 minute instruction in mouth opening exercises by a nurse before onset of radiotherapy treatment.

1

EXPERIMENTAL

physiotherapy

Other: physiotherapy

Interventions

50 patients in this group get the existing hospital treatment: A 10 minute instruction in mouth opening exercises by a nurse. Furthermore they receive in all 6-7 sessions of physiotherapy treatment for a 5-6 weeks period with sessions of approximately 45 minutes. 2 months after having completed radiotherapy treatment they receive a final physiotherapy treatment. The treatment consists of instruction in active and passive exercises for mouth opening, stretching exercises for the neck and shoulder region, tongue exercises, mimic exercises, self administered lymph drainage and softening of fibrotic tissue.

Also known as: Physiotherapy treatment
1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with the clinical diagnosis of cancer cavi oris or cancer oropharynges undergoing radiotherapy treatment
  • Age \> 18 years
  • Informed consent

You may not qualify if:

  • Patients who have had bone reconstruction surgery or grafting or where motor nerve damage has occurred during surgery, inflicting the function of the neck or shoulder
  • Patients suffering from a known musculoskeletal disease with symptoms that may influence/disturb the picture of symptoms induced by radiotherapy to the tempora-mandibular joint, the cervical spine, shoulders (e.g R.A, fibromyalgia, arthritis,neurological disease, industrial injury)
  • Patient with psychiatric diagnosis, who are unable to cooperate (including dementia)
  • Patients whose general condition makes it impossible to attend the study (weak and feeble)
  • Patients who do not master the Danish language in a degree, that they can read and understand written and verbal information
  • The lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Occupational and Physical Therapy, 8511

Copenhagen, Copenhagen Ø, 2100, Denmark

Location

Related Publications (1)

  • Hogdal N, Juhl C, Aadahl M, Gluud C. Early preventive exercises versus usual care does not seem to reduce trismus in patients treated with radiotherapy for cancer in the oral cavity or oropharynx: a randomised clinical trial. Acta Oncol. 2015 Jan;54(1):80-7. doi: 10.3109/0284186X.2014.954677. Epub 2014 Sep 17.

MeSH Terms

Conditions

Mouth NeoplasmsOropharyngeal NeoplasmsRadiation InjuriesTrismusLymphedemaFibrosis

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Head and Neck NeoplasmsNeoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsPharyngeal DiseasesOtorhinolaryngologic DiseasesWounds and InjuriesSpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsLymphatic DiseasesHemic and Lymphatic DiseasesPathologic Processes

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Nina Høgdal

    Department of Occupational and Physical Therapy, Copenhagen University Hospital, Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 24, 2008

First Posted

October 27, 2008

Study Start

December 1, 2008

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

July 2, 2013

Record last verified: 2012-07

Locations